Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Kapiteijn

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Current Opinion in Oncology|October 11, 2019
Malignant pheochromocytoma and paraganglioma: management optionsEleonora P M Corssmit, Marieke Snel, Ellen Kapiteijn
JAMA Oncology|June 20, 2020
Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint InhibitorsKarijn P M Suijkerbuijk, Ellen Kapiteijn, Rik J Verheijden
European Journal of Cancer (Oxford, England : 1990)|June 22, 2026
Percutaneous hepatic perfusion versus best alternative care as treatment for metastatic uveal melanoma: A meta-analysisLinde van den Hoek, Olaf Dekkers, Mark Burgmans, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2012
Severe colitis while responding to ipilimumab in metastatic melanomaMarije Slingerland, Johan W R Nortier, Roeland A Veenendaal, et al.
Melanoma Research|March 25, 2025
Do cortisol and psychological distress levels impact the effectiveness of immunotherapy in patients with metastasized melanoma? A pilot studyChris Hinnen, Frederiek Tijssens, Emma von Haeseler, et al.
Annals of Internal Medicine|September 20, 2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune DiseaseMonique K van der Kooij, Karijn P M Suijkerbuijk, Olaf M Dekkers, et al.
Melanoma Research|November 2, 2021
Management of heterogeneous tumor response patterns to immunotherapy in patients with metastatic melanomaDaan Jan Willem Rauwerdink, Els van Persijn van Meerten, Jos van der Hage, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 22, 2025
[Neurological side-effects associated with immune checkpoint inhibitors]Wouter W van Willigen, Dieuwke A Schreurs, Frank M Speetjens, et al.
Cancers|November 11, 2022
Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma TreatmentsSylvia A van Laar, Ellen Kapiteijn, Kim B Gombert-Handoko, et al.
Cancers|June 29, 2019
Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor TypesMonique K van der Kooij, Frank M Speetjens, Sjoerd H van der Burg, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Current Opinion in Oncology|October 11, 2019
Malignant pheochromocytoma and paraganglioma: management optionsEleonora P M Corssmit, Marieke Snel, Ellen Kapiteijn
JAMA Oncology|June 20, 2020
Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint InhibitorsKarijn P M Suijkerbuijk, Ellen Kapiteijn, Rik J Verheijden
European Journal of Cancer (Oxford, England : 1990)|June 22, 2026
Percutaneous hepatic perfusion versus best alternative care as treatment for metastatic uveal melanoma: A meta-analysisLinde van den Hoek, Olaf Dekkers, Mark Burgmans, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2012
Severe colitis while responding to ipilimumab in metastatic melanomaMarije Slingerland, Johan W R Nortier, Roeland A Veenendaal, et al.
Melanoma Research|March 25, 2025
Do cortisol and psychological distress levels impact the effectiveness of immunotherapy in patients with metastasized melanoma? A pilot studyChris Hinnen, Frederiek Tijssens, Emma von Haeseler, et al.
Annals of Internal Medicine|September 20, 2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune DiseaseMonique K van der Kooij, Karijn P M Suijkerbuijk, Olaf M Dekkers, et al.
Melanoma Research|November 2, 2021
Management of heterogeneous tumor response patterns to immunotherapy in patients with metastatic melanomaDaan Jan Willem Rauwerdink, Els van Persijn van Meerten, Jos van der Hage, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 22, 2025
[Neurological side-effects associated with immune checkpoint inhibitors]Wouter W van Willigen, Dieuwke A Schreurs, Frank M Speetjens, et al.
Cancers|November 11, 2022
Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma TreatmentsSylvia A van Laar, Ellen Kapiteijn, Kim B Gombert-Handoko, et al.
Cancers|June 29, 2019
Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor TypesMonique K van der Kooij, Frank M Speetjens, Sjoerd H van der Burg, et al.
Pageof 16